Ideal Cures Launches Two New Film Coating Products INSTACOAT QD and INSTACOAT T2F at the 2nd FDD Conclave
MUMBAI, July 5, 2018 /PRNewswire/ --
In a joint initiative, Ideal Cures - India's foremost film-coating and pharmaceutical excipient company - along with Express Pharma, India's leading pharmaceutical and biotechnology publication, in their endeavor to recognize and appreciate FR&D scientists conceptualized, initiated and sponsored the 'Formulation and Drug Delivery Leadership Awards' at the Formulation and Drug Delivery (FDD) Conclave 2018. In its second year, FDD Leadership Awards held on 15 June 2018, Hyderabad, saw over 110 formulation scientists come together, to celebrate and recognize the efforts of their colleagues. It was by virtue of quality nominations received that the award ceremony was a grand success. A jury team set up in 2017, assessed and analyzed each application and chose the crème de la crème based on pre-decided criteria. Depending upon an individual's years of experience, applicants were classified into three categories - Rising Stars, Leaders and Stalwarts. The second edition brought promises of industry leaders working together to better policies and usher in ground-breaking innovations.
(Logo: https://mma.prnewswire.com/media/714539/Ideal_Cures_Logo.jpg )
(Photo: https://mma.prnewswire.com/media/714568/Winners_FDD_Leadership_Awards_2018.jpg )
The event also saw an impressive product launch by Ideal Cures wherein a live product demo was conducted for their Quick Disintegrating Coating - INSTACOAT QD. With a disintegration time of anywhere between 3-15 secs, their new product was well received and is targeted to soon begin commercialization. Their other product - INSTACOAT T2F, targets the nutraceutical and pharmaceutical market that is on the increased look out for a coating free of both Talc and Titanium Di-oxide. INSTACOAT T2F has features at par with coatings that contain these two ingredients. These coatings are specifically formulated to provide easy scale-up and transfer to different manufacturing facilities.
Speaking on the launch, Mr. Suresh Pareek - Managing Director, Ideal Cures, said, "The mission of Ideal Cures is simply to 'Add Value'. We strive to add value to our customer's products through our renowned focus, innovation and creative thinking. Both our new innovations are based on this simple motto."
FDD Conclave 2018, humored to be an 'alumini meet', gives the industry's influencers a chance to meet their peers of over 30 decades. Being the first platform that awards and felicitates formulation scientists, FDD Conclave is poised on a growth trajectory that's only heading upwards.
About Ideal Cures:
Ideal Cures (IC) is amongst India's leading manufacturer and exporter of pharmaceutical excipients and ready-to-use coating systems for solid oral dosage forms. IC provides tailor-made solutions and products for the pharmaceutical and allied industries, through a network of customers and partners across more than 40 countries around the world. It is the first film coating company to have all its cGMP compliant manufacturing plants EXCiPACT™ certified. IC's latest manufacturing facility in Sikkim will be certified in due course. An ISO 9001:2015 certified company with a US DMF for all its manufacturing facilities, IC is one of the most innovative film-coating companies.
Website - http://www.idealcures.com
For a comprehensive, time-saving tablet coating experience, Talk to Us!
Join us on LinkedIn for quick updates on our new product launches and upcoming events!
Media Contact:
Saryu Pareek Gupta
pareeksaryu@idealcures.co.in
+91-22-42688700
Vice President - Corporate Communications
Ideal Cures Pvt. Ltd.
Upcoming Life Sciences Events
- April 2024
- Singapore: Asia Bio Partnering Forum
- London: LSX World Congress
- May 2024
- Seoul: BIO KOREA 2024